Clinical Trial Site

Clayton 3168

1 studies enrolling now · 4 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment — Stopped early